METHODS: Retrospective analysis was performed on clinical, radiological, and follow-up data of patients consecutively treated with TLM at a tertiary academic center between November 2011 and August 2021 for T1 glottic squamous cell carcinoma involving the anterior commissure. Recurrence-free survival (RFS), local control with laser alone (LCL), laryngeal preservation (LP), and overall survival (OS) rates (Kaplan-Meier) were the primary outcome metrics.
RESULTS: In our series, 5-year OS probability was 75.1%, RFS was 64.8%, LCL was 73.8%, and LP was 83.4%. OS and RFS were higher in patients with early stages of AC pattern than in patients with advanced stage (p = 0.004, p = 0.034, respectively). Vertical extension ratio was found to be associated with OS and RFS (p = 0.023, p = 0.001, respectively), and thyroid cartilage interlaminar angle with LCL by multiple Cox regression analysis (p = 0.041).
CONCLUSIONS: TLM remains a valuable treatment option for AC involvement. AC3 type involvement and elevated vertical extension ratio were associated with negative prognosis. There have been signs that thyroid cartilage with a narrow angle increases recurrence. Alternative modalities should be kept in mind in the treatment decision of these cases.
方法:对临床、放射学,以及2011年11月至2021年8月在三级学术中心连续接受TLM治疗的T1声门鳞状细胞癌累及前连合的患者的随访数据.无复发生存率(RFS),单独使用激光(LCL)的局部控制,喉保存(LP),和总生存(OS)率(Kaplan-Meier)是主要结局指标.
结果:在我们的系列中,5年OS概率为75.1%,RFS为64.8%,LCL为73.8%,LP为83.4%。早期AC型患者的OS和RFS高于晚期患者(分别为p=0.004,p=0.034)。发现垂直扩展比与OS和RFS相关(分别为p=0.023,p=0.001),和甲状软骨层间角度与LCL经多重Cox回归分析(p=0.041)。
结论:TLM仍然是AC受累的有价值的治疗选择。AC3型受累和垂直延伸比升高与阴性预后相关。有迹象表明,狭窄角度的甲状软骨会增加复发。在这些病例的治疗决定中应牢记其他方式。